Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,3411,360 of 20,252 grants

Active OTHER RESEARCH-RELATED
Science of Community Outreach and Engagement (SoCOE) Conference
NATIONAL CANCER INSTITUTE Mayo Clinic Jacksonville United States 2024 – 2029

PROJECT SUMMARY Community outreach and engagement (COE) has become the gold standard in addressing health disparities and closing the health gaps in minoritized and marginalized co...

$100K
USD
Completed OTHERS
Understand the mechanisms through which genetics, biology, and social determinants affect cancer risk and outcomes in diverse populations, to motivate interventions to reduce cancer inequities
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2025

Overall Abstract Prostate, breast and pancreatic cancers all have a disproportionately higher rate of aggressive tumor grade and early onset in Black patients, with recent spikes o...

$2.82M
USD
Completed OTHERS
Societal, Ancestry, Molecular and Biological Analyses of Inequalities: SAMBAI
NATIONAL CANCER INSTITUTE University of Nottingham United Kingdom 2024 – 2025

SAMBAI: Societal, Ancestry, Molecular and Biological Analyses of Inequalities Research Abstract Background Prostate, breast, and pancreatic cancers all have a disproportionately hi...

$699.3K
USD
Completed OTHERS
SAMBAI-Columbia
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2024 – 2025

SAMBAI: Societal, Ancestry, Molecular and Biological Analyses of Inequalities Research Abstract Background Prostate, breast, and pancreatic cancers all have a disproportionately hi...

$4.22M
USD
Completed OTHERS
PROTECT - Harnessing PROTEin degradation for Advanced Childhood Tumors
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2025

eRA ASSIST for NCI – PROTECT Title: PROTECT – Harnessing PROTEin degradation for Advanced Childhood Tumors Abstract: Background Survival rates for children with solid tumors, inclu...

$9.36M
USD
Completed OTHERS
MATCHMAKERS - large-scale generation of reactive TCR-pMHC pairs from human NSCLC
NATIONAL CANCER INSTITUTE University College London United Kingdom 2024 – 2025

Abstract Understanding how T cell receptors (TCRs) see tumor antigens presented by MHCs is necessary to fully understand how the immune system recognizes tumor antigens, and to rea...

$1.69M
USD
Completed OTHERS
MATCHMAKERS - Solving T-cell receptor recognition and design via integrated high-throughput screening and structural, functional and computational approaches
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2025

Abstract Understanding how T cell receptors (TCRs) see tumor antigens presented by MHCs is necessary to fully understand how the immune system recognizes tumor antigens, and to rea...

$2.34M
USD
Completed OTHERS
MATCHMAKERS - SOLVING TCR RECOGNITION AND DESIGN VIA INTEGRATED HIGH-THROUGHPUT SCREENING, STRUCTURAL, FUNCTIONAL, AND COMPUTATIONAL APPROACHES
NATIONAL CANCER INSTITUTE Oslo University Hospital, Rikshospitalet NORWAY 2024 – 2025

Abstract Understanding how T cell receptors (TCRs) see tumor antigens presented by MHCs is necessary to fully understand how the immune system recognizes tumor antigens, and to rea...

$740.4K
USD
Completed OTHERS
Societal, Ancestry, Molecular AND Biological Analyses Of Inequalities (SAMBAI)
NATIONAL CANCER INSTITUTE University of Pretoria South Africa 2024 – 2025

SAMBAI: Societal, Ancestry, Molecular and Biological Analyses of Inequalities Research Abstract Background Prostate, breast, and pancreatic cancers all have a disproportionately hi...

$708.3K
USD
Completed OTHERS
PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
NATIONAL CANCER INSTITUTE Harvard University United States 2024 – 2025

ABSTRACT Our vision is to unravel and ultimately reverse the intricate network of causal factors throughout the life course that disrupts biological homeostasis to promote colorect...

$4.07M
USD
Completed OTHERS
PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2024 – 2025

ABSTRACT Our vision is to unravel and ultimately reverse the intricate network of causal factors throughout the life course that disrupts biological homeostasis to promote colorect...

$2.12M
USD
Completed OTHERS
SAMBAI - Social, Ancestry, Molecular Biology analyses of Inequities
NATIONAL CANCER INSTITUTE New York Genome Center United States 2024 – 2025

SAMBAI: Societal, Ancestry, Molecular and Biological Analyses of Inequalities Research Abstract – New York Genome Center Background Prostate, breast, and pancreatic cancers all hav...

$2.59M
USD
Completed OTHERS
SAMBAI: Societal, Ancestry and Molecular Biology Analyses of Inequalities
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2025

SAMBAI: Societal, Ancestry, Molecular and Biological Analyses of Inequalities Research Abstract Background Prostate, breast, and pancreatic cancers all have a disproportionately hi...

$1.46M
USD
Completed OTHERS
PROTECT - Harnessing PROTEin degradation for Advanced Childhood Tumors
NATIONAL CANCER INSTITUTE University of Oxford United Kingdom 2024 – 2025

eRA ASSIST for NCI – PROTECT Title: PROTECT – Harnessing PROTEin degradation for Advanced Childhood Tumors Abstract: Background Survival rates for children with solid tumors, inclu...

$1.02M
USD
Completed OTHERS
MGH- PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2025

ABSTRACT Our vision is to unravel and ultimately reverse the intricate network of causal factors throughout the life course that disrupts biological homeostasis to promote colorect...

$5.77M
USD
Completed OTHERS
SAMBAI - Yemaachi Biotech
NATIONAL CANCER INSTITUTE Yemaachi Biotech Ghana 2024 – 2025

SAMBAI: Societal, Ancestry, Molecular and Biological Analyses of Inequalities Research Abstract Background Prostate, breast, and pancreatic cancers all have a disproportionately hi...

$2.35M
USD
Completed NON-SBIR/STTR RPGS
Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia
NATIONAL CANCER INSTITUTE Oregon State University United States 2024 – 2026

Project Summary Cachexia is a debilitating metabolic disorder that affects 50% of all cancer patients. Numerous clinical trials confirmed that the wasting of skeletal muscle mass i...

$4.39M
USD
Completed NON-SBIR/STTR RPGS
The histone demethylase JMJD1C in human Acute Myeloid Leukemia
NATIONAL CANCER INSTITUTE J. Craig Venter Institute, Inc United States 2024 – 2026

PROJECT SUMMARY Current therapy for acute myeloid leukemia (AML) is inadequate. Despite newly available therapeutics agents, the overall survival rate for patients with the disease...

$4.63M
USD
Active NON-SBIR/STTR RPGS
Targeting Replication Stress and DNA Damage Response in Uterine Cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

PROJECT SUMMARY Uterine cancer (UC) incidence and death rates are both significantly increasing in the United States. Most UCs are endometrial cancers which arise from the inner li...

$29.72M
USD
Active NON-SBIR/STTR RPGS
Combined ATR and P13k inhibition in uterine cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

Project Summary Replication stress (RS) is defined as the slowing or stalling of the replication fork progression during DNA synthesis and is widely recognized as a significant cau...